Shares in South Korean drug contract manufacturer Samsung BioLogics rose as much as 5.2per cent in early Monday trade, after it agreed to fill-finish manufacture Moderna's COVID-19 vaccine.
from Latest News https://ift.tt/2QJapo7
Samsung BioLogics shares rise after agrees to make Moderna COVID-19 vaccine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment